Arbutus Biopharma Corporation ABUS Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on trailing twelve months.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's asset turnover?
- Arbutus Biopharma Corporation (ABUS) reported asset turnover of 1× in Q1 2026.
- How has Arbutus Biopharma Corporation's asset turnover changed year-over-year?
- Arbutus Biopharma Corporation's asset turnover increased by 1928.0% year-over-year, from 0× to 1×.
- What is the long-term trend for Arbutus Biopharma Corporation's asset turnover?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's asset turnover has grown at a 16.9% compound annual growth rate (CAGR), from 0.1× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.